Literature DB >> 18627038

Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.

Catalina García-Nonell1, Eugenia Rigau Ratera, Susan Harris, David Hessl, Michele Y Ono, Nicole Tartaglia, Emily Marvin, Flora Tassone, Randi J Hagerman.   

Abstract

This study examined whether secondary medical diagnoses that affect CNS function (i.e., seizures, malformations, or genetic disorders), are more likely to occur in individuals with fragile X syndrome (FXS) and autism spectrum disorder (FXS + ASD) or FXS alone. Ninety males (3-25 years) with FXS or FXS + ASD were evaluated for secondary medical diagnoses by medical history and examination. A significant difference in the incidence of medical problems was found between patients with FXS + ASD (38.6%) and FXS alone (18.2%, P < 0.05). Medical problems that affect the CNS are more likely to occur in those with FXS + ASD and it is probable that additional brain dysfunction associated with these medical problems enhance the risk of autism in those with FXS. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18627038      PMCID: PMC4097171          DOI: 10.1002/ajmg.a.32290

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  42 in total

1.  Epilepsy in autism and autisticlike conditions. A population-based study.

Authors:  I Olsson; S Steffenburg; C Gillberg
Journal:  Arch Neurol       Date:  1988-06

2.  Phenotypic involvement in females with the FMR1 gene mutation.

Authors:  J E Riddle; A Cheema; W E Sobesky; S C Gardner; A K Taylor; B F Pennington; R J Hagerman
Journal:  Am J Ment Retard       Date:  1998-05

3.  Familial transmission of the FMR1 CGG repeat.

Authors:  S L Nolin; F A Lewis; L L Ye; G E Houck; A E Glicksman; P Limprasert; S Y Li; N Zhong; A E Ashley; E Feingold; S L Sherman; W T Brown
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

4.  The Prader-Willi-like phenotype in fragile X patients: a designation facilitating clinical (and molecular) differential diagnosis.

Authors:  B B De Vries; M F Niermeijer
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

5.  46XY/47XYY mosaicism and fragile X.

Authors:  J Bodurtha; C Jackson-Cook; A Maddalena; J Piserchio; R Waller
Journal:  Clin Genet       Date:  1993-08       Impact factor: 4.438

Review 6.  Neurobiology of autism.

Authors:  I Rapin; R Katzman
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

7.  Origin of the supernumerary X chromosome in a patient with fragile X and Klinefelter syndrome.

Authors:  K G Kupke; A L Soreng; U Müller
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

8.  46,XY/47,XYY male with the fragile X syndrome: cytogenetic and molecular studies.

Authors:  A Milunsky; X Huang; J A Amos; J Herskowitz; L A Farrer; H E Wyandt
Journal:  Am J Med Genet       Date:  1993-03-01

9.  A controlled study of longitudinal IQ changes in females and males with fragile X syndrome.

Authors:  C Wright-Talamante; A Cheema; J E Riddle; D W Luckey; A K Taylor; R J Hagerman
Journal:  Am J Med Genet       Date:  1996-08-09

10.  Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.

Authors:  B B de Vries; J P Fryns; M G Butler; F Canziani; E Wesby-van Swaay; J O van Hemel; B A Oostra; D J Halley; M F Niermeijer
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

View more
  43 in total

1.  Clinical report: a male with Down syndrome, fragile X syndrome, and autism.

Authors:  Lindsay Stevens; Nicole Tartaglia; Randi Hagerman; Karen Riley
Journal:  J Dev Behav Pediatr       Date:  2010-05       Impact factor: 2.225

Review 2.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

3.  Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.

Authors:  Weerasak Chonchaiya; Jacky Au; Andrea Schneider; David Hessl; Susan W Harris; Meredith Laird; Yi Mu; Flora Tassone; Danh V Nguyen; Randi J Hagerman
Journal:  Hum Genet       Date:  2011-10-15       Impact factor: 4.132

4.  Emotion recognition and visual-scan paths in Fragile X syndrome.

Authors:  Tracey A Shaw; Melanie A Porter
Journal:  J Autism Dev Disord       Date:  2013-05

5.  Consistency between research and clinical diagnoses of autism among boys and girls with fragile X syndrome.

Authors:  J Klusek; G E Martin; M Losh
Journal:  J Intellect Disabil Res       Date:  2014-02-17

6.  Grammar in Boys With Idiopathic Autism Spectrum Disorder and Boys With Fragile X Syndrome Plus Autism Spectrum Disorder.

Authors:  Audra Sterling
Journal:  J Speech Lang Hear Res       Date:  2018-04-17       Impact factor: 2.297

Review 7.  Fragile X: a family of disorders.

Authors:  Weerasak Chonchaiya; Andrea Schneider; Randi J Hagerman
Journal:  Adv Pediatr       Date:  2009

8.  Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation.

Authors:  R Nick Hernandez; Rachel L Feinberg; Rebecca Vaurio; Natalie M Passanante; Richard E Thompson; Walter E Kaufmann
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

9.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

10.  Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome.

Authors:  Weerasak Chonchaiya; Flora Tassone; Paul Ashwood; David Hessl; Andrea Schneider; Luis Campos; Danh V Nguyen; Randi J Hagerman
Journal:  Hum Genet       Date:  2010-09-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.